688293 奥浦迈
已收盘 09-30 15:00:00
资讯
新帖
简况
9月30日奥浦迈涨6.77%，招商医药健康产业股票基金重仓该股
证券之星 · 09-30
9月30日奥浦迈涨6.77%，招商医药健康产业股票基金重仓该股
奥浦迈（688293）披露2026年第四次临时股东会会议资料，9月29日股价下跌0.37%
证券之星 · 09-29
奥浦迈（688293）披露2026年第四次临时股东会会议资料，9月29日股价下跌0.37%
9月29日奥浦迈发生1笔大宗交易 成交金额367.2万元
证券之星 · 09-29
9月29日奥浦迈发生1笔大宗交易 成交金额367.2万元
股市必读：奥浦迈生物新发布《奥浦迈：关于持股5%以下特定股东减持股份计划公告》
证券之星 · 09-28
股市必读：奥浦迈生物新发布《奥浦迈：关于持股5%以下特定股东减持股份计划公告》
奥浦迈生物（688293）9月24日主力资金净卖出2538.50万元
证券之星 · 09-25
奥浦迈生物（688293）9月24日主力资金净卖出2538.50万元
奥浦迈(688293.SH)特定股东国寿成达拟减持不超1%股份
智通财经 · 09-24
奥浦迈(688293.SH)特定股东国寿成达拟减持不超1%股份
9月24日奥浦迈生物跌8.88%，招商医药健康产业股票基金重仓该股
证券之星 · 09-24
9月24日奥浦迈生物跌8.88%，招商医药健康产业股票基金重仓该股
9月23日奥浦迈生物涨12.69%，招商医药健康产业股票基金重仓该股
证券之星 · 09-23
9月23日奥浦迈生物涨12.69%，招商医药健康产业股票基金重仓该股
奥浦迈（688293）披露2026年限制性股票与股票增值权激励计划预留授予（第一批次）公告，9月22日股价下跌0.03%
证券之星 · 09-22
奥浦迈（688293）披露2026年限制性股票与股票增值权激励计划预留授予（第一批次）公告，9月22日股价下跌0.03%
9月21日奥浦迈生物涨6.72%，招商医药健康产业股票基金重仓该股
证券之星 · 09-21
9月21日奥浦迈生物涨6.72%，招商医药健康产业股票基金重仓该股
每周股票复盘：奥浦迈生物（688293）奥浦迈2026上半年营收4.54亿
证券之星 · 09-20
每周股票复盘：奥浦迈生物（688293）奥浦迈2026上半年营收4.54亿
奥浦迈：9月15日召开业绩说明会，投资者参与
证券之星 · 09-17
奥浦迈：9月15日召开业绩说明会，投资者参与
奥浦迈(688293.SH)：上海磐信拟减持不超3%股份
智通财经 · 09-14
奥浦迈(688293.SH)：上海磐信拟减持不超3%股份
股市必读：奥浦迈新发布《奥浦迈：关于公司独立董事离任的公告》
证券之星 · 09-14
股市必读：奥浦迈新发布《奥浦迈：关于公司独立董事离任的公告》
每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜
证券之星 · 09-13
每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜
9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股
证券之星 · 09-10
9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股
9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元
证券之星 · 09-08
9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元
9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股
证券之星 · 09-08
9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股
异动快报：奥浦迈（688293）9月8日14点6分触及涨停板
证券之星 · 09-08
异动快报：奥浦迈（688293）9月8日14点6分触及涨停板
电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身
澎湃新闻 · 09-07
电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身
加载更多
公司概况
公司名称：
上海奥浦迈生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-09-02
主营业务：
上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日，公司拥有已授权的知识产权合计281项，其中，发明专利32项，实用新型专利100项，外观设计专利2项，软件著作权66项及其他81项。
发行价格：
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":79.61,"timestamp":1790751600000,"preClose":74.56,"halted":0,"volume":8067846,"delay":0,"changeRate":0.0677,"floatShares":117000000,"shares":142000000,"eps":0.9015,"marketStatus":"已收盘","change":5.05,"latestTime":"09-30 15:00:00","open":74.12,"high":82.12,"low":73.68,"amount":633000000,"amplitude":0.1132,"askPrice":79.61,"askSize":64,"bidPrice":79.59,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.9015,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":74.56,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":82.02,"lowLimit":67.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":142194199,"isCdr":false,"pbRate":3.6,"roa":"--","peRate":88.308375,"roe":"4.32%","epsLYR":0.37,"committee":-0.056995,"marketValue":11320000000,"turnoverRate":0.0689,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","afterMarket":{"amount":31844,"volume":400,"close":79.61,"buyVolume":3875,"sellVolume":0,"time":1790753637746,"indexStatus":"已收盘 09-30 15:30:00","preClose":74.56},"floatMarketCap":9328000000},"requestUrl":"/m/hq/s/688293","defaultTab":"news","newsList":[{"id":"2671774274","title":"9月30日奥浦迈涨6.77%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671774274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671774274?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:34","pubTimestamp":1790757293,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日奥浦迈涨6.77%，收盘报79.61元，换手率6.89%，成交量8.07万手，成交额6.33亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000025790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671101732","title":"奥浦迈（688293）披露2026年第四次临时股东会会议资料，9月29日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671101732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671101732?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:03","pubTimestamp":1790690598,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，奥浦迈报收于74.56元，较前一交易日下跌0.37%，最新总市值为106.02亿元。该股当日开盘74.92元，最高77.61元，最低73.7元，成交额达4.31亿元，换手率为4.89%。近日，奥浦迈发布《2026年第四次临时股东会会议资料》公告。公告显示，公司拟召开2026年第四次临时股东会，审议续聘立信会计师事务所为2026年度审计机构的议案，并对公司董事会进行换届选举。现场会议将于2026年10月15日在公司会议室举行，同时提供网络投票方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900039561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421887","title":"9月29日奥浦迈发生1笔大宗交易 成交金额367.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671421887?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:36","pubTimestamp":1790674573,"startTime":"0","endTime":"0","summary":"证券之星消息，9月29日奥浦迈发生大宗交易，交易数据如下：大宗交易成交价格73.44元，相对当日收盘价折价1.5%，成交5万股，成交金额367.2万元，买方营业部为广发证券股份有限公司江门万达广场证券营业部，卖方营业部为国泰海通证券股份有限公司长宁区江苏路证券营业部。近三个月该股共发生36笔大宗交易，合计成交4.27万手，折价成交36笔。截至2026年9月29日收盘，奥浦迈报收于74.56元，下跌0.37%，换手率4.89%，成交量5.72万手，成交额4.31亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900029152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409814","title":"股市必读：奥浦迈生物新发布《奥浦迈：关于持股5%以下特定股东减持股份计划公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409814","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409814?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:05","pubTimestamp":1790528713,"startTime":"0","endTime":"0","summary":"大宗交易9月24日奥浦迈生物发生381.45万元大宗交易。公司公告汇总奥浦迈：关于持股5%以下特定股东减持股份计划公告截至公告披露日，国寿成达持有奥浦迈股份6,538,966股，占公司总股本的4.60%，股份来源于首次公开发行前取得，已全部解除限售。减持价格将根据二级市场价格确定，且已承诺遵守相关法律法规及减持规则。本次减持计划与此前承诺一致，不存在导致控制权变更的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419130","title":"奥浦迈生物（688293）9月24日主力资金净卖出2538.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670419130?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:21","pubTimestamp":1790295711,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，奥浦迈生物报收于77.45元，下跌8.88%，换手率5.99%，成交量7.02万手，成交额5.57亿元。近5日资金流向一览见下表：奥浦迈生物融资融券信息显示，融资方面，当日融资买入4771.78万元，融资偿还7586.28万元，融资净偿还2814.5万元。奥浦迈生物主营业务：从事细胞培养产品与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669465462","title":"奥浦迈(688293.SH)特定股东国寿成达拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669465462","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669465462?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:05","pubTimestamp":1790240720,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥浦迈(688293.SH)发布公告，公司持股5%以下特定股东国寿成达(上海)健康产业股权投资中心(有限合伙)(简称“国寿成达”)计划自2026年10月26日起至2027年1月25日期间，通过集中竞价交易的方式减持公司股份不超过142.19万股，合计减持数量占公司目前总股本的比例不超过1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669546310","title":"9月24日奥浦迈生物跌8.88%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669546310?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:38","pubTimestamp":1790239099,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日奥浦迈生物跌8.88%，收盘报77.45元，换手率5.99%，成交量7.02万手，成交额5.57亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669109966","title":"9月23日奥浦迈生物涨12.69%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669109966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669109966?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:37","pubTimestamp":1790152672,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日奥浦迈生物涨12.69%创60日新高，收盘报85.0元，换手率7.53%，成交量8.82万手，成交额7.3亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140208","title":"奥浦迈（688293）披露2026年限制性股票与股票增值权激励计划预留授予（第一批次）公告，9月22日股价下跌0.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140208","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669140208?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:18","pubTimestamp":1790086707,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，奥浦迈报收于75.43元，较前一交易日下跌0.03%，最新总市值为107.26亿元。近日，奥浦迈发布《关于2026年限制性股票与股票增值权激励计划向激励对象授予预留部分限制性股票的公告》。本次授予的限制性股票为第二类限制性股票，归属安排分为三期，分别在授予日起12个月、24个月、36个月后归属，比例分别为40%、30%、30%。预计股份支付费用总额为633.77万元，将在2026年至2029年间摊销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200041677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159150","title":"9月21日奥浦迈生物涨6.72%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159150?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:42","pubTimestamp":1789980125,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日奥浦迈生物涨6.72%创60日新高，收盘报75.45元，换手率7.05%，成交量8.26万手，成交额6.1亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906445","title":"每周股票复盘：奥浦迈生物（688293）奥浦迈2026上半年营收4.54亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906445","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906445?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:22","pubTimestamp":1789838531,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，奥浦迈生物报收于70.7元，较上周的65.1元上涨8.6%。本周，奥浦迈生物9月18日盘中最高价报75.5元，股价触及近一年最高点。来自机构调研要点：澎立生物2026上半年实现净利润2,766.11万元。答：2026年上半年公司实现营业收入4.54亿元,实现归母净利润1.24亿元。2026年上半年,澎立生物贡献营业收入2.22亿元,占公司总收入的48.85%,其中,药物临床前 CRO 实现收入1.82亿元,医疗器械临床前CRO 实现收入2,064.16万元,实验动物销售1,208.72万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963986","title":"奥浦迈：9月15日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963986","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668963986?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:32","pubTimestamp":1789637553,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月15日奥浦迈发布公告称公司于2026年9月15日召开业绩说明会。报告期内,公司研发费用3,625.75万元,占营业收入的比例约8%。截至2026年6月30日,公司拥有已授权的知识产权合计281项,其中,发明专利32项,实用新型专利100项,外观设计专利2项,软件著作权66项及其他81项。从2025年下半年开始,CXO生物药行业需求逐步复苏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700027344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634896","title":"奥浦迈(688293.SH)：上海磐信拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634896","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667634896?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:46","pubTimestamp":1789386378,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥浦迈(688293.SH)发布公告，北京磐茂投资管理有限公司-磐信(上海)投资中心(有限合伙)(简称“上海磐信”)计划自2026年10月14日起至2027年1月13日期间，通过大宗交易和集中竞价交易的方式合计减持公司股份不超过426.58万股，合计减持数量占公司目前总股本的比例不超过3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"奥浦迈(688293.SH)：上海磐信拟减持不超3%股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667680198","title":"股市必读：奥浦迈新发布《奥浦迈：关于公司独立董事离任的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680198?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:06","pubTimestamp":1789322773,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，奥浦迈报收于65.1元，下跌2.63%，换手率3.75%，成交量4.39万手，成交额2.86亿元。当日关注点交易信息汇总：9月11日主力资金净流出1000.18万元，占总成交额3.49%。其原定任期至2026年10月16日。截至公告日，文光伟先生未持有公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667507465","title":"每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667507465?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:25","pubTimestamp":1789237513,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，奥浦迈报收于65.1元，较上周的54.62元上涨19.19%。本周，奥浦迈9月9日盘中最高价报73.15元，股价触及近一年最高点。本周关注点来自交易信息汇总：奥浦迈因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。其原定任期至2026年10月16日。在公司股东会选举产生新任独立董事前，文光伟先生将继续履行相关职责。公司董事会对文光伟先生在任职期间的贡献表示感谢。截至公告日，文光伟先生未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566449","title":"9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666566449?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:37","pubTimestamp":1789029461,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日奥浦迈跌5.80%，收盘报66.86元，换手率5.6%，成交量6.56万手，成交额4.42亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000029183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329497","title":"9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665329497?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:53","pubTimestamp":1788861184,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月8日公布的交易公开信息显示，奥浦迈因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月8日收盘，奥浦迈报收于68.29元，上涨20.0%，涨停，换手率7.29%，成交量8.54万手，成交额5.32亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入5350.29万元，北向资金合计净买入734.85万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800027751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532516","title":"9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665532516?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:39","pubTimestamp":1788856795,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日奥浦迈涨20.00%，收盘报68.29元，换手率7.29%，成交量8.54万手，成交额5.32亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800026124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665834718","title":"异动快报：奥浦迈（688293）9月8日14点6分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665834718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665834718?lang=zh_cn&edition=full","pubTime":"2026-09-08 14:15","pubTimestamp":1788848130,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息，14点6分奥浦迈（688293）触及涨停板。其所属行业生物制品目前上涨。领涨股为奥浦迈。该股为医药，创新药概念热股，当日医药概念上涨1.75%，创新药概念上涨1.59%。9月7日的资金流向数据方面，主力资金净流入1262.34万元，占总成交额5.95%，游资资金净流入32.97万元，占总成交额0.16%，散户资金净流出1295.32万元，占总成交额6.11%。近5日资金流向一览见下表：奥浦迈主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800018748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315098","title":"电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315098","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665315098?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:20","pubTimestamp":1788776400,"startTime":"0","endTime":"0","summary":"公募机构及百亿基金经理最新调研动向揭晓。公募排排网数据显示，上周（2026年8月31日-9月6日）共有142家公募机构参与A股调研活动中，覆盖到27个申万一级行业中的175只个股，合计调研次数达1428次，延续了较高的调研热情。从行业分布看，公募机构对11个行业的调研不少于50次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866808185.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866808185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0008368742.USD","IE0031814852.USD","LU0359201612.USD","000636","BK0028","688322","BK0224","BK0077","BK0279","LU0359202008.SGD","LU0823426308.USD","002270","LU2424517915.HKD","LU1997245094.SGD","002507","BK0012","300661","LU0594300179.USD","BK0216","688800","300498","LU0650527681.SGD","LU0084288322.USD","LU1328277881.USD","LU1688375341.USD","LU1794554557.SGD","LU1813983027.USD","BK0109","LU1720050803.USD","LU2039709279.SGD","688293","LU2348774022.SGD","300760","IE00BZ08YT58.USD","LU2153592121.USD","LU0594300419.USD","LU2488822045.USD","IE00BZ08YR35.GBP","001232","LU0405327494.USD","300900","BK0226","IE00B031J352.USD","301345","LU1934453819.USD","BK0187","LU0823426480.USD","LU2153591404.USD","LU1997245177.USD","BK0125"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791311036162,"stockEarnings":[{"period":"1week","weight":-0.0634},{"period":"1month","weight":0.4992},{"period":"3month","weight":0.8551},{"period":"6month","weight":0.7792},{"period":"1year","weight":0.2453},{"period":"ytd","weight":0.6322}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6012人(较上一季度增加23.20%)","perCapita":"21024股","listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","registeredCapital":"14219万元","survey":" 上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日，公司拥有已授权的知识产权合计281项，其中，发明专利32项，实用新型专利100项，外观设计专利2项，软件著作权66项及其他81项。","listedPrice":80.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}